Furthermore, Klosowska-Wardega et al. [33] could show that pharmacological inhibition of PDGF- and VEGF-mediated signaling lead to a reduction of tumour IFP and to an improved therapeutic effect of taxol that needs to penetrate into the tumour in order to exert its effects. This evidence concerns the gene VEGFA and neoplasm.